Goldline Pharmaceutical Ltd Share Price

Pharmaceuticals

BSE: 544759 Small Cap ISIN: INE1CLW01015

As on 13 June 2026 at 03:43 IST

₹46.35

-1.70

(-3.54%)

Sell Buy

Over 1 Month

-15.36%

Over 6 Months

None%

Over 1 Year

None%

Over 3 Years

None%

Goldline Pharmaceutical Ltd Summary

Close ₹48.05

Open ₹48.95

High ₹49.93

Low ₹45

Volume 2,13,000

Net Turnover (in Cr) ₹1.01

52Wk High ₹60

52Wk Low ₹41.76

52Wk High / Low

41.76

Goldline Pharmaceutical Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹46.13

EPS (TTM) -

Book Value (BV) 21

Div. Yield -

P/E (TTM) -

Price/Book Value 2.29

Delivery % 60.56 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 12.71

ROE 38.74

Debt-Equity 1.22

Net Profit Margin 10.09

Operating Profit Margin 21.60

Goldline Pharmaceutical Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	28.06	23.57	19.85
Total Expenses	24.20	21.04	19.45
Profit Before Tax	3.86	2.53	0.40
Profit After Tax	2.83	1.81	0.26
Operating Profit After Depreciation	5.58	4.14	2.02

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	2.89	2.95	2.50
Total Non Current Assets	2.93	3.43	2.57
Total Current Assets	23.35	19.50	16.82
Total Assets	26.28	22.93	19.39
Total Shareholder's Fund	10.35	7.87	5.89

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Net Cash From Operating Activities	2.32	2.92	2.39
Net Cash Used In Investing Activities	0.16	-1.11	-1.04
Net Cash Used In Financing Activities	-2.03	-1.08	-1.44

No data available

Particulars (in ₹ Cr.)	2026-03	2025-12
Total Revenue	-	-
Total Expenses	-	-
Profit Before Tax	-	-
Profit After Tax	1.89	0.87
Operating Profit after Depreciation	-	-

Goldline Pharmaceutical Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 45.39

S2 42.73

S3 40.46

Pivot 47.66

R1 50.32

R2 52.59

R3 55.25

Moving Average

20 SMA -

50 SMA -

100 SMA -

200 SMA -

Goldline Pharmaceutical Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Goldline Pharmaceutical Ltd Top Mutal Funds Invested

No data available

Goldline Pharmaceutical Ltd News

Goldline Pharmaceutical to discuss results

On 9 June 2026

03 Jun 2026, 12:43 pm

BSE SME Goldline Pharmaceutical delivers a dose of listing gains

Goldline Pharmaceutical traded at Rs 56.77 on the BSE, a 32.02% premium to the issue price of Rs 43.

19 May 2026, 11:49 am

Goldline Pharmaceutical Ltd Stock Analysis

Annual revenue for Goldline Pharmaceutical Ltd increased by 19.05% to ₹28.06 crore in FY 2025 from ₹23.57 crore in FY 2024.
Annual Net Profit for Goldline Pharmaceutical Ltd increased by 56.93% to ₹2.83 crore in FY 2025 from ₹1.81 crore in FY 2024.
Promoter Shareholding in Goldline Pharmaceutical Ltd remains unchanged by 0.00% in the most recent quarter, from 79.71% in May 2026 to 79.71% in May 2026.
Goldline Pharmaceutical Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Goldline Pharmaceutical Ltd share price moved down by 3.54% from its previous close of INR ₹48.05. The latest Goldline Pharmaceutical Ltd share price is INR ₹46.35.
Goldline Pharmaceutical Ltd share price today has been at a low of 46.35 and a high of 46.50. Over the past 52 weeks, the Goldline Pharmaceutical Ltd share price has seen a low of 41.76 and a high of 60.